Company Filing History:
1 out of 321 
1 out of 549 
Years Active: 2017
Title: JiHye Ryu: Innovator in Monoclonal Antibody Research
Introduction
JiHye Ryu is a notable inventor based in Gyeongsangnam-do, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on innovative solutions for treating various medical conditions, including cancer and liver fibrosis.
Latest Patents
JiHye Ryu holds a patent for a monoclonal antibody that specifically binds to the TM4SF5 protein. This invention relates to a novel monoclonal antibody that targets the human TM4SF5 protein. The patent encompasses various applications, including methods for treating liver fibrosis, cancer treatment, inhibiting cancer metastasis, and diagnosing cancer. The comprehensive nature of her patent highlights its potential impact on medical research and therapeutic development.
Career Highlights
Throughout her career, JiHye Ryu has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and the SNU RDB Foundation. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
JiHye Ryu has collaborated with notable colleagues, including Se Mi Kim and Sang Jick Kim. These partnerships have fostered a collaborative environment that enhances the quality and scope of her research.
Conclusion
JiHye Ryu's innovative work in monoclonal antibody research positions her as a key figure in biotechnology. Her contributions have the potential to advance medical treatments and improve patient outcomes.